Delisting risk
Aptevo Therapeutics (APVO)
Developer of multispecific cancer immunotherapies and radiopharmaceutical oncology programs.
$2.32
Pre-market−0.30 (−11.45%)
At close$2.62(+11.97%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$3.72
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$82.37−$1,579.14−$151.08−$40.11$1,684.47−$6.41−$5.31Pending
Estimate−$7.75−$1,514.39−$0.45−$37.59−$8.09−$5.60−$6.02−$3.72
Surprise−962.8%−4.3%−33,473.3%−6.7%+20,921.6%−14.5%+11.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$3.72 | — | — |
| Aug 2026 | −$6.02 | −$5.31 | +11.8% |
| May 2026 | −$5.60 | −$6.41 | −14.5% |
| Mar 2026 | −$8.09 | $1,684.47 | +20,921.6% |
| Nov 2025 | −$37.59 | −$40.11 | −6.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$3.72 | — | — | — | — | — | — |
| Aug 14, 2026 | −$6.02 | −$5.31 | +11.8% | — | — | — | −13.5% |
| May 13, 2026 | −$5.60 | −$6.41 | −14.5% | — | — | — | +0.8% |
| Mar 20, 2026 | −$8.09 | $1,684.47 | +20,921.6% | — | — | — | −1.5% |
| Nov 6, 2025 | −$37.59 | −$40.11 | −6.7% | — | — | — | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 11, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 25, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 13, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 12, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 26, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||